NRXBF and J90 Related Headlines

Go Back

Aug 28, 2026 04:01PM NurExone Biologic Inc. to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference
Jul 28, 2026 05:24PM NurExone names David Stolick to board, hires investor firm
Jul 28, 2026 05:24PM Corporate Updates – NurExone appoints Mr. David Stolick to the Board of Directors
Jun 30, 2026 08:31AM NurExone closes private placement raising C$627,795
Jun 30, 2026 08:31AM NurExone Announces Closing of Non-Brokered Private Placement
Jun 1, 2026 08:02AM NurExone Announces First Quarter 2026 Financial Results and Provides Corporate Update
May 19, 2026 04:04PM NurExone Receives Notice of Patent Grant in South Korea Covering ExoPTEN Technology
Apr 27, 2026 04:03PM Australian Patent Granted to NurExone Covering Stem Cell-Derived Exosome Production
Apr 16, 2026 09:15AM NurExone Biologic Inc. Announces Fourth Quarter and Full-Year 2025 Financial Results and Provides Corporate Update
Feb 27, 2026 04:03PM NurExone to Showcase Its Regenerative Medicine Platform at NANO.IL.2026 and Advanced Therapies Congress in March 2026 and Provides Corporate Update
Dec 19, 2025 04:04PM NurExone Reports Anti-Inflammatory Activity of Its Exosomes in Lab Analysis
Nov 12, 2025 04:02PM NurExone Secures over C$3.18 Million Through Accelerated Warrant Exercises
Nov 3, 2025 04:04PM NurExone Accepted into ARMI’s BioFab Startup Lab Strengthening U.S Position in Regenerative Manufacturing

NRXBF and J90 Related Press Releases

Go Back

Aug 28, 2026 04:01PM NurExone Biologic Inc. to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference
Jul 28, 2026 05:24PM Corporate Updates – NurExone appoints Mr. David Stolick to the Board of Directors
Jun 30, 2026 08:31AM NurExone Announces Closing of Non-Brokered Private Placement
Jun 1, 2026 08:02AM NurExone Announces First Quarter 2026 Financial Results and Provides Corporate Update
May 19, 2026 04:04PM NurExone Receives Notice of Patent Grant in South Korea Covering ExoPTEN Technology
Apr 27, 2026 04:03PM Australian Patent Granted to NurExone Covering Stem Cell-Derived Exosome Production
Apr 16, 2026 09:15AM NurExone Biologic Inc. Announces Fourth Quarter and Full-Year 2025 Financial Results and Provides Corporate Update
Feb 27, 2026 04:03PM NurExone to Showcase Its Regenerative Medicine Platform at NANO.IL.2026 and Advanced Therapies Congress in March 2026 and Provides Corporate Update
Dec 19, 2025 04:04PM NurExone Reports Anti-Inflammatory Activity of Its Exosomes in Lab Analysis
Nov 12, 2025 04:02PM NurExone Secures over C$3.18 Million Through Accelerated Warrant Exercises
Nov 3, 2025 04:04PM NurExone Accepted into ARMI’s BioFab Startup Lab Strengthening U.S Position in Regenerative Manufacturing

NRXBF and J90 Related SEC Filings

Go Back